Blood pressure: how to measure, manage, and treat high blood pressure (AMA #48 rebroadcast)
In a Nutshell
Aggressive blood pressure control to <120 systolic cuts cardiovascular events ~25% and all-cause mortality ~27% within 3 years. Measure twice daily for two weeks under standardized conditions (5 min rest, proper cuff size/placement, arm at heart level) before making decisions. Lifestyle changes—weight loss (~1 mmHg per kg), 90-150 min weekly zone-2 exercise, potassium-rich diet—often match single-drug effects, but most patients ultimately need an ACEi/ARB or CCB to reach target.
These notes were generated by AI and may contain inaccuracies.
The Drive Podcast is hosted by Peter Attia. The podcast, website, and weekly newsletter focus on translating the science of longevity into accessible content. All content is provided without paid ads and is made possible entirely by members who receive exclusive member-only content and benefits.
This episode is a rebroadcast of a previous AMA focused on blood pressure. Blood pressure is one of the most important and overlooked risk factors for chronic disease. Many people either do not know their numbers or don't appreciate how profoundly blood pressure influences long-term health. The AMA covers what blood pressure measures and why it matters for longevity, how to accurately measure blood pressure at home, why office readings can be misleading, the relationship between blood pressure and cardiovascular disease, dementia, kidney disease, and overall mortality, the latest evidence on optimal blood pressure targets, lifestyle interventions including weight loss, exercise, nutrition, and sleep that impact blood pressure, when medications become necessary and how different treatment classes work, and practical strategies for monitoring and managing blood pressure over the long term.
Cardiovascular disease has three main risk factors: smoking, Apo B, and blood pressure. Unlike Apo B which requires lab testing, blood pressure can be checked at home and monitored throughout the day. The discussion will cover what high and low blood pressure mean, what they affect beyond cardiovascular disease risk, different definitions, and what can be done to control blood pressure through lifestyle factors and medications.
The heart pumps blood through two phases of cardiac contraction. Systole occurs when the ventricles contract, with the left ventricle being the muscular one responsible for pumping blood against systemic resistance to the body. This is the systemic circulation being discussed. Pulmonary blood pressure, controlled by the right ventricle, is significantly lower and not covered in this discussion.
During systole, blood leaves the heart through the aortic valve into the aorta. The pressure experienced by blood pushing against artery walls during this phase is the higher systolic number. Diastole is the relaxation phase when the ventricle fills through the atria. The heart itself receives its blood supply during diastole, while all other organs receive blood during systole. Even during diastole, there is still a tonic amount of pressure within the artery wall.
A blood pressure reading like 125 over 79 means 125 mm of mercury is the pressure when the heart squeezes and blood leaves the aorta, while 79 mm of mercury is the pressure when the ventricle relaxes and fills.
Prior to 2017, definitions allowed more leeway. Current guidelines updated after the SPRINT trial in 2015 define normal blood pressure as systolic at or below 120 mm of mercury and diastolic less than 80 mm of mercury. Elevated blood pressure is systolic between 120 and 129 with diastolic less than 80. Stage one hypertension is systolic between 130 and 139 or diastolic between 80 and 89. Stage two hypertension is systolic exceeding 140 or diastolic exceeding 90.
The SPRINT trial published in 2015 asked what the benefit of aggressive blood pressure control would be. The study included just under 10,000 people with systolic blood pressure of 130 or greater who were at advanced cardiovascular risk but did not have type 2 diabetes. Participants were randomized into intensive treatment targeting systolic blood pressure less than 120 versus standard treatment targeting less than 140.
The average blood pressure at baseline was about 140 over 78. Blood pressure was measured rigorously using an office visit protocol where patients sat for 5 minutes doing nothing with back supported and legs uncrossed, then had three automated cuff readings taken 5 minutes apart, with the blood pressure deemed as the average of all three readings.
At one year, average systolic blood pressure was 121.4 mm of mercury in the intensive group versus 136.2 in the standard group. The study was stopped early after just over 3 years median follow-up due to significant benefits in the intensive group.
The primary outcome was a composite of cardiovascular mortality reduction showing about a 25% relative reduction with hazard ratio of 0.75 and absolute risk difference of about 0.54% over one year. At the 3-year mark, total event rate was approximately 1.6% lower in the intensive group for the primary composite outcome including myocardial infarction, acute coronary syndrome, stroke, acute heart failure, and cardiovascular death.
All-cause mortality was reduced 27% with 1.2% absolute risk reduction. This included reduction in cardiovascular disease death specifically at 2x reduction, but also benefits in kidney disease, accidental death, suicide, and homicide.
Compounding is powerful with blood pressure as with smoking and Apo B. These are area under the curve problems involving endothelial exposure. Elevated blood pressure causes mechanical disruption to the endothelium, smoking causes chemical disruption, and Apo B is the concentration of lipoprotein that goes through disrupted endothelium causing pathologic events.
A blood pressure of 119 over 78 would be considered very favorable. Blood pressure measurement has far more heterogeneity than Apo B measurement. Decisions are never made on single readings but require two weeks of checking blood pressure two to three times a day under perfect conditions before considering what is high or low.
With Apo B, you cannot go too low, but with blood pressure, you can go too low and risk symptoms like orthostasis (lightheadedness when standing) from overmedication.
The overall prevalence of stage one and stage two hypertension in the United States is about 46% based on surveys collecting blood pressure measurements or self-reported anti-hypertensive medications. This represents a significant hidden epidemic among people who haven't been to the doctor in years.
Approximately 30% of men and just under 20% of women aged 20 to 44 have hypertension. In middle age, 45 to 55 years old, prevalence rises to 50% in men and 44% in women. By age 75 and older, prevalence exceeds 80% for both men and women. African-Americans have the highest prevalence at 59% for men and 56% for women. Non-Hispanic white prevalence is 47% for men and 41% for women. Non-Hispanic Asian prevalence is 45% for men and 36% for women. Hispanic prevalence is 44% for men and 42% for women. Men have higher prevalence in younger years, but rates converge with age. Hypertension is described as a silent epidemic with no demographic group exempt from risk.
For individuals aged 20 to 44 with high blood pressure, an additional 40 to 60 years of lifespan means the condition compounds over decades. The longer hypertension remains undetected and unmanaged, the greater the cumulative damage to organs and vasculature.
Framingham Heart Study data from the 1960s demonstrated that reducing blood pressure from above 140 over 90 to below that threshold was associated with 35 to 40% reduction in stroke, 50% reduction in cardiovascular disease overall, 64% reduction in heart failure, and 15 to 25% reduction in myocardial infarction. Meta-analyses show that for adults aged 40 to 70, each 20 mmHg increase in systolic blood pressure and each 10 mmHg increase in diastolic blood pressure doubles the risk of death from stroke, heart disease, or other vascular disease. The SPRINT trial demonstrated 25 to 30% year-on-year relative risk reduction with intensive blood pressure control, including benefits in all-cause mortality.
The 2021 STEP trial randomized 8,500 Chinese adults aged 60 to 80 with isolated systolic hypertension to intensive systolic blood pressure targets of 110 to 130 versus standard targets of 130 to 150. Mean baseline blood pressure was 146 over 83. After a median follow-up of slightly over 3 years, the intensive group achieved a 26% reduction in cardiovascular outcomes and a 28% reduction in cardiovascular disease mortality. Absolute risk reductions were approximately 1% per year. The trial did not include people with diabetes.
High blood pressure damages small vessels in three primary organs: heart, brain, and kidneys. The kidneys receive 20 to 25% of cardiac output despite comprising only 1 to 2% of body weight, making them highly susceptible to elevated pressures. Patients with hypertension experience faster age-adjusted decline in renal perfusion and reduced glomerular filtration rate. Cystatin C is used as a superior biomarker to creatinine for monitoring kidney function. A GFR of 60 mL/min is technically considered normal but is not age-appropriate for a 50-year-old, where 100 mL/min would be expected.
The SPRINT MIND trial, a subset of the SPRINT cohort with over 9,000 subjects, examined intensive blood pressure lowering on dementia risk. Absolute risk reduction for dementia was 6%, with relative risk reduction of 16%. This aligns with observational data and long-term prospective studies showing consistent benefits of blood pressure control for brain health.
Low blood pressure lacks a strict numerical diagnosis and is defined by symptoms rather than specific values. Blood pressure below 90 over 60 is generally considered low. Some individuals tolerate 100 over 70 without orthostatic symptoms, while others develop dizziness, lightheadedness, fainting, lack of concentration, or blurred vision at the same level. Weight loss and exercise can lower blood pressure in patients on medication, requiring careful dose reduction to avoid inducing hypotensive symptoms.
High blood pressure is often called a silent killer because it produces no warning signs. Headaches and other symptoms are not reliable indicators. Accurate measurement is the only way to determine if hypertension is present.
Blood pressure should be measured after 3 to 5 minutes of rest with no phone use or conversation. The cuff must be the correct size and placed directly on skin, not over clothing. The back must be supported with feet flat on the ground and legs uncrossed. A full bladder can raise readings by 10 to 15 mmHg. Being in pain can increase readings by 10 to 30 mmHg. Arm position matters: for every inch the arm is below heart level, readings increase by approximately 2 mmHg, and the reverse applies when the arm is above heart level.
Using a manual cuff and stethoscope, the cuff is placed about one inch above the antecubital fossa crease over the brachial artery on the medial side. The cuff is inflated until the pulse disappears, then 30 mmHg beyond that point. As pressure is slowly released, the first tapping sound heard is the systolic reading. The sound eventually muffles and stops, marking the diastolic reading. Automated cuffs are convenient but may be 10 to 15 mmHg off, often overestimating systolic values. Manual readings are more consistent and accurate.
Blood pressure should naturally drop 10 to 20% during sleep due to horizontal positioning and reduced sympathetic tone. Continuous blood pressure monitoring over multiple days reveals whether this nocturnal dip occurs. Transient stress can significantly elevate readings, with systolic values routinely exceeding 140 mmHg during periods of irritability or sympathetic activation.
An increase in systolic blood pressure during exercise is completely normal. During V2 max testing, patients have blood pressure checked alongside the test. The normal physiology shows systolic pressure rises while diastolic stays about the same or even goes down. This occurs because vasodilation of the arterioles, which provides more oxygen to muscles during exercise, causes a reduction in systemic vascular resistance.
Blood pressure during exercise can reach 180 to 200 millimeters of mercury. Peak blood pressure during heavy deadlifts or squats likely reaches even higher levels. For patients with very dilated aortas, heavy Valsalva-type maneuvers might not be advisable.
Valsalva refers to any action that significantly increases intra-abdominal pressure. This occurs when bearing down heavily, such as when picking up very heavy objects or performing heavy squats, which causes significant increases in blood pressure.
Secondary hypertension is high blood pressure caused by a correctable other medical condition. About 10% of people diagnosed with hypertension have a secondary cause. The remaining cases are considered primary hypertension (formerly called "essential hypertension"), where the cause is unknown.
Clues suggesting secondary hypertension include:
- Medication resistance: when treatment for high blood pressure has no effect or when patients stop responding to previously effective medications
- Extremely high blood pressure (north of 180 mmHg systolic)
- Sudden onset or sudden increase in blood pressure
- Young age (such as 30-year-olds) with no risk factors like family history or obesity
A case example involves a serious athlete who had blood pressure readings of 180-190 over 120 in the morning. Exercise would temporarily lower it slightly, but readings remained generally high. Multiple medications had no effect. After an MRI from prior surgery revealed an adrenal nodule (initially missed by radiologists), testing confirmed a pheochromocytoma - a tumor of the adrenal glands that secretes catecholamines. Surgical removal of the affected adrenal gland normalized his blood pressure completely.
Additional secondary causes to rule out include:
- Kidney disease
- Renal artery stenosis
- Thyroid conditions
- Hyperaldosteronism (can be idiopathic, caused by corticosteroid use, or from adrenal gland hypoplasia)
Family history is a significant factor. Both parents having hypertension increases awareness of potential genetic predisposition. Despite lifestyle measures to maintain low blood pressure, genetic factors may eventually overcome lifestyle interventions, requiring medication. Frequent blood pressure monitoring helps detect when this transition occurs.
Lifestyle interventions have a greater impact on blood pressure than on lipids. Unlike lipid management, where extreme dietary interventions create additional problems, blood pressure responds well to weight loss, exercise, reduced insulin resistance, avoiding type 2 diabetes, and good sleep.
Meta-analysis data shows that for every kilogram of weight loss, systolic blood pressure reduces by slightly more than 1 mmHg and diastolic by almost 1 mmHg. Weight loss is accomplished through reducing intake via caloric restriction, dietary restriction, time restriction, or combinations thereof.
Significant heterogeneity exists in population sodium sensitivity. Some people are more sensitive to dietary sodium from a blood pressure perspective. Salt sensitivity is more common in:
- African-Americans
- Older people
- People who already have higher blood pressure
- People with metabolic syndrome, diabetes, or chronic kidney disease
Rick Johnson's recommendation is to drink water with or before salty meals, as thirst following salty meals indicates sodium levels have already risen.
Extreme sodium restriction to 500 mg per day (from average American intake of 3.5-4.5 grams daily) can reduce systolic blood pressure by 5-6 mmHg in hypertensive individuals, but meta-analysis from the Institute of Medicine shows this level increases all-cause mortality.
Increasing dietary potassium through potassium-rich foods (bananas, potatoes) rather than supplements can lower blood pressure through the relationship between potassium and aldosterone in the kidney.
Meta-analysis of RCTs lasting at least four weeks found endurance exercise reduced systolic blood pressure by up to 8 mmHg and diastolic by at least 5 mmHg in hypertensive patients. The optimal protocol was 90-150 minutes weekly at 65-75% of maximum heart rate (zone 2 training).
Dynamic resistance training reduces systolic blood pressure by about 2 mmHg and diastolic by about 3 mmHg with 90-150 minutes weekly at 50-100% of one-rep max. Isometric resistance training showed greater reductions: approximately 6 mmHg systolic and 3 mmHg diastolic.
Insulin resistance reduces nitric oxide bioavailability, which normally increases vasodilation. Biomarkers like SDMA and ADMA are elevated in people with high homocysteine or impaired renal function. Type 2 diabetes creates a triple burden through:
- High glucose load causing microvascular damage to heart, brain, and kidney
- Blood pressure damage
- Increased ApoB burden from hypertriglyceridemia requiring more LDL particles
Both sleep deprivation and insomnia drive hypertension. Very long or very short sleep increases hypertension risk, with up to 40% increased risk when sleeping less than 5 hours or more than 10 hours nightly. Sleeping more than 10 hours may proxy for chronic disease or heavily fragmented sleep.
Four first-line drug categories for hypertension:
- Thiazide diuretics
- Calcium channel blockers
- ACE inhibitors
- ARBs (angiotensin 2 receptor blockers)
Beta blockers are not used as first-line agents. All first-line agents typically reduce systolic blood pressure by 12-15 mmHg and diastolic by 9-11 mmHg. ACE inhibitors and ARBs work at about half the recommended maximum dose. ARBs are considered slightly better than ACE inhibitors in efficacy and side effects, though ACE inhibitors are cheaper and more widely available.
Thiazide diuretics and calcium channel blockers achieve similar blood pressure reductions (15 mmHg systolic, 9-10 mmHg diastolic) but tend to have more side effects, making them better as add-on agents rather than first-line treatments.
Individual blood pressure medications have larger effects than any single lifestyle factor, but the combined impact of all lifestyle factors can be at least on par with pharmacologic treatment. Approximately half of people with hypertension might manage it without medication.
- Heart failure or reduced ejection fraction: avoid calcium channel blockers due to effects on cardiac contractility
- Type 2 diabetes and chronic kidney disease: both ACE inhibitors and ARBs are reasonable options (textbook preference for ACE inhibitors lacks strong supporting data)
- Renal artery stenosis: avoid ACE inhibitors and ARBs
- Gout, significant hyperlipidemia, type 2 diabetes: avoid diuretics due to increased insulin resistance
- Pregnancy or history of angioedema: avoid ACE inhibitors and ARBs
- African-Americans: thiazide diuretics or calcium channel blockers might be more effective
In African-American patients, thiazide diuretics or calcium channel blockers might actually be more effective than ACE inhibitors, ARBs, or beta blockers when it comes to reducing cardiovascular events.
Beta blockers and alpha blockers are not considered first-line treatments today, though they are still used in specific situations.
This session covered the majority of questions received on blood pressure, including follow-up details on how people should think about blood pressure, why they should care, why they should care early and often, how to monitor blood pressure, what lifestyle factors can affect it, and how to think about medications if needed.
This overview was compiled because blood pressure has been discussed recently but never in as much depth as other risk factors like APOB.
Blood pressure represents an important part of the longevity playbook, though it is not considered "sexy" compared to interventions like taking rapamycin or drugs targeting senescent cells. Despite being basic primary care medicine, blood pressure management is highly impactful.
It is viewed as catastrophic when people focus on biohacking approaches while ignoring their blood pressure.
The podcast is for general informational purposes only and does not constitute the practice of medicine, nursing, or other professional healthcare services, including the giving of medical advice. No doctor-patient relationship is formed.
The use of this information and materials linked to the podcast is at the user's own risk. The content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Users should not disregard or delay in obtaining medical advice from healthcare professionals for any medical conditions.
All conflicts of interest are taken seriously, with an up-to-date list of disclosures available at peteratti.com/about.
Keep Peter Attia MD in your library
Save the videos and channels worth coming back to, and find them again in one place.
